The cannabinoid receptor-1 antagonist rimonabant inhibits platelet activation and reduces pro-inflammatory chemokines and leukocytes in Zucker rats - Schafer, A; Pfrang, J; Neumuller, J; Fiedler, S; Ertl, G; Bauersachs, J (Br J Pharmacol, 2008)